Praxis Precision Medicines Income Statement (2019-2026) | PRAX

Income Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
0.68M0.78M0.47M0.52M0.43M0.36M0.30M7.46M
Operating items
Research & Development (Quarter)
33.14M43.51M52.65M43.62M30.44M28.33M25.50M25.61M17.26M18.39M26.98M27.26M41.88M56.29M60.81M63.01M65.80M77.51M77.99M69.42M
Selling, General & Administrative (Quarter)
11.63M15.15M16.20M16.77M13.85M13.12M13.27M10.13M8.72M9.93M15.33M10.59M15.26M15.13M13.92M13.06M12.56M19.54M27.87M27.49M
Operating Expenses (Quarter)
44.77M58.66M68.85M60.39M44.29M41.45M38.77M35.74M25.98M28.32M42.32M37.84M57.14M71.42M74.73M76.07M78.36M97.04M105.86M96.90M
Operating Income (Quarter)
-44.77M-58.66M-68.85M-60.39M-44.29M-41.45M-38.09M-34.96M-25.52M-27.81M-41.89M-37.49M-56.84M-63.96M-74.73M-76.07M-78.36M-97.04M-105.86M-96.90M
EBIT (Quarter)
-44.77M-58.66M-68.85M-60.39M-44.29M-41.45M-38.09M-34.96M-25.52M-27.81M-41.89M-37.49M-56.84M-63.96M-74.73M-76.07M-78.36M-97.04M-105.86M-96.90M
Non-operating items
Interest & Investment Income (Quarter)
-0.43M-0.07M0.14M1.32M0.15M0.02M0.00M-0.07M1.40M0.01M-0.26M-2.16M-1.08M
Other Non Operating Income (Quarter)
0.07M0.13M0.20M0.34M0.28M0.64M0.65M0.88M0.93M2.33M4.81M4.92M5.28M5.43M4.94M4.42M8.13M13.30M13.18M
Non Operating Income (Quarter)
0.07M0.07M0.13M0.20M0.34M0.28M0.64M0.65M0.88M0.93M2.33M4.81M4.92M5.28M5.43M4.94M4.42M8.13M13.30M13.18M
Net income details
EBT (Quarter)
-44.70M-58.59M-83.31M-61.22M-43.95M-184.07M-37.96M-35.01M-25.74M-208.31M-56.08M-39.27M-68.23M-282.26M-75.84M-77.90M-87.02M-506.98M-562.09M-564.12M
Tax Provisions (Quarter)
0.01M-0.01M
Profit After Tax (Quarter)
-44.70M-58.58M-68.72M-60.19M-43.95M-41.17M-37.45M-34.31M-24.63M-26.88M-39.55M-32.68M-51.91M-58.68M-69.30M-71.13M-73.93M-88.94M-92.60M-84.80M
Income from Continuing Operations (Quarter)
-44.70M-58.58M-83.31M-61.22M-43.95M-184.07M-37.96M-35.01M-25.74M-208.31M-56.08M-39.27M-68.23M-282.26M-75.84M-77.90M-87.02M-506.98M-562.09M-564.12M
Consolidated Net Income (Quarter)
-44.70M-58.58M-83.31M-61.22M-43.95M-184.07M-37.96M-35.01M-25.74M-208.31M-56.08M-39.27M-68.23M-282.26M-75.84M-77.90M-87.02M-506.98M-562.09M-564.12M
Income towards Parent Company (Quarter)
-44.70M-58.58M-83.31M-61.22M-43.95M-184.07M-37.96M-35.01M-25.74M-208.31M-56.08M-39.27M-68.23M-282.26M-75.84M-77.90M-87.02M-506.98M-562.09M-564.12M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-44.70M-58.58M-83.31M-61.22M-43.95M-184.07M-37.96M-35.01M-25.74M-208.31M-56.08M-39.27M-68.23M-282.26M-75.84M-77.90M-87.02M-506.98M-562.09M-564.12M
Additional items
EPS (Basic) (Quarter)
-15.00-20.70-27.49-20.16-14.40-59.89-10.72-7.53-2.85-31.59-4.03-2.09-3.61-15.76-3.60-3.63-3.96-22.53-19.46-19.36
EPS (Diluted) (Quarter)
-15.00-20.70-27.49-20.16-14.40-59.89-10.72-7.53-2.85-31.59-4.03-2.09-3.61-15.76-3.60-3.63-3.96-22.53-19.46-19.36
Shares Outstanding (Quarter)
2.98M2.83M3.03M3.04M3.05M3.07M3.54M4.65M9.04M6.59M13.90M18.82M18.88M17.91M21.06M21.47M21.98M22.50M28.88M29.13M
Shares Outstanding (Diluted) (Quarter)
2.98M2.83M3.03M3.04M3.05M3.07M3.54M4.65M9.04M6.59M13.90M18.82M18.88M17.91M21.06M21.47M21.98M22.50M28.88M29.13M
Shares Outstanding (Entity) (Quarter)
2.99M3.02M3.03M3.04M3.12M3.29M3.86M4.65M8.57M6.59M13.26M17.76M17.79M19.42M20.34M21.04M21.17M25.20M27.86M27.92M
EBITDA (Quarter)
-44.77M-58.66M-68.85M-60.39M-44.29M-41.45M-38.09M-34.96M-25.52M-27.81M-41.89M-37.49M-56.84M-63.96M-74.73M-76.07M-78.36M-97.04M-105.86M-96.90M
Interest Expenses (Quarter)
54.15M86.00M14.03M0.75M0.54M143.93M0.02M0.07M0.22M180.50M14.20M1.71M12.80M218.30M1.12M1.57M8.66M409.94M454.07M466.14M
Tax Rate (Quarter)
-0.01%0.01%